作者
Nikhil C. Munshi,Larry D. Anderson,Nina Shah,Deepu Madduri,Jesús G. Berdeja,Sagar Lonial,Noopur Raje,Yi Lin,David S. Siegel,Albert Oriol,Philippe Moreau,Ibrahim Yakoub‐Agha,Michel Delforge,Michèle Cavo,Hermann Einsele,Hartmut Goldschmidt,Katja Weisel,Alessandro Rambaldi,Donna Reece,Fabio Petrocca,Monica Massaro,Jamie N. Connarn,Shari M. Kaiser,Payal Patel,Liping Huang,Timothy B. Campbell,Kristen Hege,Jesús F. San Miguel
摘要
Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expected CAR T-cell toxic effects in patients with relapsed and refractory multiple myeloma.
薰硝壤
不配.
浅尝离白
Singularity
Henry
8R60d8
shinysparrow
juziyaya
个性的紫菜
xiaxiao
iNk
有人
咖啡豆
寻道图强
HEIKU
Leonardi
竹筏过海
毛豆爸爸
pcr163
肯德鸭
皖公网安备34019202002308
